Elizabeth Griffiths

23PUBLICATIONS
193CO-AUTHORS
Regenerative medicine (incl. stem cells)Gene and molecular therapyHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Dec 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.

Kai Yu, Laura W Dillon, Jesse M Tettero

|Oct 31, 2025
Decitabine-cedazuridine in patients with MDS and TP53 mutations.

Samuel Urrutia, Koji Sasaki, Alex Bataller

|Jul 11, 2025
Platelet glycosylation in myelodysplastic syndromes correlates with disease severity.

Katelyn E Rosenbalm, Tin Long Wong, Donny Hoang

Pageof 4

Frequent Collaborators

8 joint publications

Hetty E Carraway

7 joint publications

Rami S Komrokji

6 joint publications

Valeria Santini

6 joint publications

Zhuoer Xie